FIND-AD: Financial Incentives and Recruitment to the APT Webstudy

Sponsor
University of Southern California (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06033066
Collaborator
American Heart Association (Other), Schaeffer Center for Health Policy & Economics (Other), Alzheimer's Therapeutic Research Institute (Other)
48,000
3
30

Study Details

Study Description

Brief Summary

This single-blind, three-arm, randomized, controlled trial will assess the impact of messages and financial incentives on the enrollment of demographically diverse individuals to the Alzheimer Prevention Trials (APT) Webstudy. The APT Webstudy is a novel, online registry that employs quarterly cognitive testing using validated platforms. The APT Webstudy implements fully remote assessments, coordinated by the Alzheimer's Therapeutic Research Institute (ATRI) under USC IRB #HS-17-00746. The purpose of the current study is to test whether we can increase enrollment of diverse individuals into the registry. To do this, we will work with Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers in Contra Costa County, California, to test whether sending messages with and without financial incentives to patients who receive primary care with the health system can increase enrollment to the APT Webstudy. The investigators hypothesize that 1) a certain small financial incentive and an award opportunity based incentive (or a drawing with a prize) will increase enrollment rates of CCHS members into the APT Webstudy relative to the control group. The investigators further hypothesize that the award opportunity incentive will increase the enrollment rate of CCRMC patients into the APT Webstudy more than a certain financial incentive with the same expected value.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Financial Incentives
  • Behavioral: Message
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
48000 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
A Randomized Trial of Financial Incentives for the Recruitment of County Health System Patients to the Alzheimer Prevention Trials (APT) Webstudy
Anticipated Study Start Date :
Sep 1, 2023
Anticipated Primary Completion Date :
Mar 1, 2026
Anticipated Study Completion Date :
Mar 1, 2026

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Messaging Only

16,000 participants will be randomized to Arm 1 where no monetary incentive is offered.

Behavioral: Message
Message inviting participant to enroll

Experimental: Small Incentive

16,000 participants will be randomized to Arm 2 where a small one-time monetary incentive is offered.

Behavioral: Financial Incentives
Small financial incentive or prize incentive

Experimental: Prize Incentive

16,000 participants will be randomized to Arm 3 where an opportunity based incentive (or a drawing with a prize) with a single winner will be offered.

Behavioral: Financial Incentives
Small financial incentive or prize incentive

Outcome Measures

Primary Outcome Measures

  1. Enrollment status into the APT Webstudy [2-weeks]

    APT Webstudy enrollment rate based on completion of at least one of the two APT Webstudy cognitive assessments (Cognitive Function Instrument [CFI] and/or Cogstate Brief Battery).

Secondary Outcome Measures

  1. Cost per enrollee [annual]

    Cost to acquire an enrollment

  2. Completion of cognitive assessments within the APT Webstudy [2-weeks]

    Completion of both APT Webstudy cognitive assessments (Cognitive Function Instrument [CFI] and/or Cogstate Brief Battery).

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:

To be eligible to participate in this study, an individual must meet all of the following criteria:

  • Patients empaneled at Contra Costa Regional Medical Center (CCRMC), the county public hospital and its affiliated health centers.

  • Age 50 or older

  • Literate in either English or Spanish

Exclusion Criteria:
  • Below age 50

  • Documentation of prior dementia diagnosis

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University of Southern California
  • American Heart Association
  • Schaeffer Center for Health Policy & Economics
  • Alzheimer's Therapeutic Research Institute

Investigators

None specified.

Study Documents (Full-Text)

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Mireille Jacobson, Associate Professor of Gerontology, University of Southern California
ClinicalTrials.gov Identifier:
NCT06033066
Other Study ID Numbers:
  • UP-22-01037
First Posted:
Sep 13, 2023
Last Update Posted:
Sep 13, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Mireille Jacobson, Associate Professor of Gerontology, University of Southern California
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 13, 2023